Latest Breaking News On - Verve therapeutics inc - Page 1 : comparemela.com

Verve Therapeutics Announces Leadership Update

Troy Lister, Ph.D., to be promoted to chief scientific officer Andrew Bellinger, M.D., Ph.D., will depart the Company and serve in an advisory capacity BOSTON, May 31, 2024 Verve.

United statesFlinders universitySouth australiaTroy listerJen robinsonAndrew bellingerSekar kathiresanAshlea kosikowskiExchange commissionScripps research instituteNovartis institutes for biomedical researchVerve therapeutics incChief scientific officerChief medical officerSpero therapeuticsNovartis institutes

Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV)

Verve Therapeutics Announces Leadership Update - Verve Therapeutics (NASDAQ:VERV)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Flinders universitySouth australiaUnited statesSekar kathiresanJen robinsonTroy listerAshlea kosikowskiAndrew bellingerExchange commissionVerve therapeutics incScripps research instituteNovartis institutes for biomedical researchChief scientific officerChief medical officerSpero therapeuticsNovartis institutes

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJen robinsonAshlea kosikowskiVerve therapeutics incStock incentive planNasdaq listing ruleVerve therapeutics

Reviewing Beam Therapeutics (NASDAQ:BEAM) and Bio-Techne (NASDAQ:TECH)

Bio-Techne (NASDAQ:TECH – Get Free Report) and Beam Therapeutics (NASDAQ:BEAM – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Risk and Volatility Bio-Techne has a beta of 1.23, […]

United kingdomUnited statesSana biotechnology incPfizer incBeam therapeutics incBio techne corporationApellis pharmaceuticalsTechne corporationVerve therapeutics incProtein sciencesGet free reportBeam therapeuticsBeam therapeuticGiven beam therapeuticMiddle eastGreater china

Verve Therapeutics (NASDAQ:VERV) Trading Down 3 6%

Verve Therapeutics (NASDAQ:VERV) Trading Down 3 6%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesAndrewd asheStifel nicolausSecurities exchange commissionRoyal bankNewbridge financial services group incQuest partnersFinancial services group incDaiwa securities group incVerve therapeutics incVerve therapeuticsGet free reportExchange commissionServices groupFinancial services groupSecurities group